Terms: = Kidney tumors AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396
38 results:
1. VDRA downregulate β-catenin/smad3 and DNA damage and repair associated with improved prognosis in ccRCC patients.
Wang P; Nie J; Li J; Ye C; Chen J; Zhang Z; Li B
Int J Biol Macromol; 2024 Apr; 263(Pt 2):130405. PubMed ID: 38403213
[TBL] [Abstract] [Full Text] [Related]
2. Transforming growth factors β and their signaling pathway in renal cell carcinoma and peritumoral space-transcriptome analysis.
Kajdaniuk D; Hudy D; Strzelczyk JK; Młynarek K; Słomian S; Potyka A; Szymonik E; Strzelczyk J; Foltyn W; Kos-Kudła B; Marek B
Clin Transl Oncol; 2024 May; 26(5):1229-1239. PubMed ID: 38085441
[TBL] [Abstract] [Full Text] [Related]
3. HOOK1 Inhibits the Progression of Renal Cell Carcinoma via TGF-β and TNFSF13B/VEGF-A Axis.
Yin L; Li W; Chen X; Wang R; Zhang T; Meng J; Li Z; Xu L; Yin R; Cheng B; Yang H
Adv Sci (Weinh); 2023 Jun; 10(17):e2206955. PubMed ID: 37085921
[TBL] [Abstract] [Full Text] [Related]
4. The living donor evaluation as a life-saving event.
Park SC; Shapiro R; Good D; Lopez R; Shah N; Sood P; Sturdevant M; Tan H; Vekasy M; Wijkstrom M; Wu C; Humar A
Clin Transplant; 2023 Jan; 37(1):e14885. PubMed ID: 36562337
[TBL] [Abstract] [Full Text] [Related]
5. Docetaxel suppressed cell proliferation through smad3/HIF-1α-mediated glycolysis in prostate cancer cells.
Peng J; He Z; Yuan Y; Xie J; Zhou Y; Guo B; Guo J
Cell Commun Signal; 2022 Dec; 20(1):194. PubMed ID: 36536346
[TBL] [Abstract] [Full Text] [Related]
6. Drug-containing serum of rhubarb-astragalus capsule inhibits the epithelial-mesenchymal transformation of HK-2 by downregulating TGF-β1/p38MAPK/smad2/3 pathway.
Qin MY; Huang SQ; Zou XQ; Zhong XB; Yang YF; Zhang YT; Mi ZC; Zhang YS; Huang ZG
J Ethnopharmacol; 2021 Nov; 280():114414. PubMed ID: 34314804
[TBL] [Abstract] [Full Text] [Related]
7. Total renal volume and renal function after radical nephrectomy in renal neoplasm.
Pampa-Saico S; Alexandru S; Pizarro-Sánchez MS; López-Picasso M; Puente-Suárez LG; Barba R; Liaño F
Nefrologia (Engl Ed); 2021; 41(4):446-452. PubMed ID: 36165113
[TBL] [Abstract] [Full Text] [Related]
8. APOBEC1 complementation factor facilitates cell migration by promoting nucleus translocation of smad3 in renal cell carcinoma cells.
Xia H; Liu Y; Xu L; Mao H; Zhou Q; Xie Y
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):501-509. PubMed ID: 34002283
[TBL] [Abstract] [Full Text] [Related]
9. Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro.
Yang MD; Sun Y; Zhou WJ; Xie XZ; Zhou QM; Lu YY; Su SB
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921192
[TBL] [Abstract] [Full Text] [Related]
10. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.
Wang H; Guo S; Kim SJ; Shao F; Ho JWK; Wong KU; Miao Z; Hao D; Zhao M; Xu J; Zeng J; Wong KH; Di L; Wong AH; Xu X; Deng CX
Theranostics; 2021; 11(5):2442-2459. PubMed ID: 33500735
[TBL] [Abstract] [Full Text] [Related]
11. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
[TBL] [Abstract] [Full Text] [Related]
12. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
[TBL] [Abstract] [Full Text] [Related]
13. Targeting newly identified ERβ/TGF-β1/smad3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.
Song W; He D; Chen Y; Yeh CR; Hsu I; Huang Q; Zhang X; Chang LS; Zuo L; Chen J; Doersch KM; Chang C; Li L; Yeh S
Mol Oncol; 2018 Dec; 12(12):2055-2071. PubMed ID: 30171816
[TBL] [Abstract] [Full Text] [Related]
14. Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.
Wei M; Mao S; Lu G; Li L; Lan X; Huang Z; Chen Y; Zhao M; Zhao Y; Xia Q
BMC Cancer; 2018 Apr; 18(1):434. PubMed ID: 29665787
[TBL] [Abstract] [Full Text] [Related]
15. PIM1 mediates epithelial-mesenchymal transition by targeting smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
[TBL] [Abstract] [Full Text] [Related]
16. Differential effects of sevoflurane on the metastatic potential and chemosensitivity of non-small-cell lung adenocarcinoma and renal cell carcinoma in vitro.
Ciechanowicz S; Zhao H; Chen Q; Cui J; Mi E; Mi E; Lian Q; Ma D
Br J Anaesth; 2018 Feb; 120(2):368-375. PubMed ID: 29406185
[TBL] [Abstract] [Full Text] [Related]
17. Sinomenine hydrochloride attenuates the proliferation, migration, invasiveness, angiogenesis and epithelial-mesenchymal transition of clear-cell renal cell carcinoma cells via targeting smad in vitro.
Zhao B; Liu L; Mao J; Liu K; Fan W; Liu J; Zhang Z; Li Q
Biomed Pharmacother; 2017 Dec; 96():1036-1044. PubMed ID: 29198924
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
Chen J; Zaidi S; Rao S; Chen JS; Phan L; Farci P; Su X; Shetty K; White J; Zamboni F; Wu X; Rashid A; Pattabiraman N; Mazumder R; Horvath A; Wu RC; Li S; Xiao C; Deng CX; Wheeler DA; Mishra B; Akbani R; Mishra L
Gastroenterology; 2018 Jan; 154(1):195-210. PubMed ID: 28918914
[TBL] [Abstract] [Full Text] [Related]
19. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing smad4 expression.
Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q
Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475
[TBL] [Abstract] [Full Text] [Related]
20. In vitro anticancer activities of osthole against renal cell carcinoma cells.
Liu L; Mao J; Wang Q; Zhang Z; Wu G; Tang Q; Zhao B; Li L; Li Q
Biomed Pharmacother; 2017 Oct; 94():1020-1027. PubMed ID: 28810525
[TBL] [Abstract] [Full Text] [Related]
[Next]
